The short answer
Provides magnesium and acts as an osmotic laxative at product-specific doses.
- Evidence and scope
- Established for an indicated use
This status does not grade the ingredient for every goal, outcome, or person.
- Important limitation
- The benefit is tied to the stated indication, dose, and population; it is not evidence of broader disease prevention or longer life.
- Before deciding
- Key concern: Avoid chronic laxative use or kidney impairment without medical guidance; separate interacting medicines.
01 / PRACTICAL GUIDE
Dose, absorption, and combinations
These are indication-specific reference or studied ranges—not a personalized prescription. Start with the objective, then check the form, label, medicines, and health conditions.
Reference or studied range—not a personalized prescription. The product label or a clinician may specify a different dose.
Dose source ↗Reference or studied range—not a personalized prescription. The product label or a clinician may specify a different dose.
Dose source ↗More is not automatically better. A clinician or product label may specify a different amount.
Water-soluble or readily water-dispersible. This does not mean excess is always harmless.
Take with water; food may improve tolerance.
Avoid chronic laxative use or kidney impairment without medical guidance; separate interacting medicines.
Dose and use links lead to primary or official source material. Search links are discovery tools, not proof that every returned paper applies.
02 / EVIDENCE
What the research says
We keep supportive, mixed, negative, safety, and contextual findings together. The headline never replaces the underlying papers.
These are audited counts for this JIVANA collection, not search-result totals. Participants are counted once when multiple papers use the same cohort; review papers are not added again to participant totals.
Open the research timelineResearch timeline+
Entries are ordered by publication year. A study period appears only when the source reports it.
Effects of Magnesium Citrate, Magnesium Oxide, and Magnesium Sulfate Supplementation on Arterial Stiffness
Citrate increased plasma and urinary magnesium, but none of the three forms significantly changed arterial stiffness or blood pressure versus placebo. Better exposure did not produce the proposed cardiovascular surrogate benefit.
Study design and methods
- Design
- Randomized, double-blind, placebo-controlled formulation-comparison trial
- Population
- 164 adults with overweight or mild obesity; mean age 63
- Intervention
- 450 mg/day magnesium as citrate, oxide, or sulfate, versus placebo
- Outcome
- Carotid-femoral pulse-wave velocity, blood pressure, and magnesium biomarkers
Assessment of bioavailability of Mg from Mg citrate and Mg oxide by measuring urinary excretion in Mg-saturated subjects
Citrate increased urinary magnesium and produced higher plasma concentrations than oxide at 4 and 8 hours. The very small, male-only, single-dose study measured absorption rather than health benefit.
Study design and methods
- Design
- Randomized crossover bioavailability trial
- Population
- 14 healthy men
- Intervention
- 400 mg magnesium as citrate or oxide
- Outcome
- 24-hour urinary magnesium and plasma magnesium through 24 hours
Mg citrate found more bioavailable than other Mg preparations in a randomised, double-blind study
Citrate produced the strongest absorption signals and greater 60-day urinary magnesium excretion than oxide; oxide did not differ from placebo. These biomarkers establish relative exposure, not better clinical outcomes.
Study design and methods
- Design
- Randomized, double-blind, placebo-controlled parallel trial
- Population
- 46 healthy adults
- Intervention
- 300 mg/day elemental magnesium as citrate, amino-acid chelate, or oxide, versus placebo
- Outcome
- Urine, serum, erythrocyte, and salivary magnesium measures
Prophylaxis of migraine with oral magnesium
Attack frequency fell 41.6% with dicitrate and 15.8% with placebo in weeks 9–12; migraine days and symptomatic medicine use also favored magnesium. Diarrhea occurred in 18.6% and gastric irritation in 4.7%.
Study design and methods
- Design
- Prospective multicenter randomized double-blind placebo-controlled trial
- Population
- 81 adults aged 18–65 with migraine
- Intervention
- Trimagnesium dicitrate providing 600 mg magnesium daily or placebo
- Outcome
- Migraine attack frequency, migraine days, symptomatic medicine use, and tolerability
Unscreened discovery appendix—not evidence175 candidate publicationsSearch run: Aug 21, 2026
Complete for the displayed PubMed query at the search timestamp—not for all databases or every possible synonym. Candidates can be irrelevant, duplicate the same study, or report negative findings. They are never summed as evidence or participants until screened.
03 / SOURCES
Start with the source material
The live search is for discovery only. Search-result counts change and are not included in the audited totals above.
Recent PubMed discovery recordsDirect links to the first 12 records returned by the reproducible search. These are discovery candidates—not reviewed summaries or a count of supportive findings.
- Efficacy of 1 L PEG Ascorbate vs Sodium Picosulfate With Magnesium Citrate Bowel Preparations for Capsule Colonoscopy and Pan-Intestinal Capsule Endoscopy: A Prospective Study.Gonçalves JC, Souto M, Magalhães J et al. · 2026 · Clinical and translational gastroenterology · PMID 41810820Open on PubMed ↗
- Magnesium supplementation did not reduce serum calciprotein crystallization and arterial stiffness in individuals with type 2 diabetes: a randomized, double-blind, placebo-controlled trial.Meer R, Xu JY, Newsom SP et al. · 2026 · The American journal of clinical nutrition · PMID 41903889Open on PubMed ↗
- Comparative Cleansing Efficacy, Safety, and Tolerability of Bowel Preparation Agents in Pediatric Patients: A Network and Proportional Meta-Analyses of Randomized Controlled Trials.Hsu WT, Ke TW, Kuo CY et al. · 2026 · Digestive diseases and sciences · PMID 41042416Open on PubMed ↗
- [Clinical efficacy of the dietary supplement Astracit-Asfarma as a synergistic adjuvant to standard therapy for the elimination of residual fragments after endoscopic and shock wave lithotripsy in patients with urolithiasis (a pilot study)].Fomkin R N, Osnovin O V, Popkov V M et al. · 2025 · Urologiia (Moscow, Russia : 1999) · PMID 42417324Open on PubMed ↗
- Comparing the Bioavailability of Two Seawater-Derived Magnesium Preparations.McFarlin BK, Paschall AL, Kelly ME et al. · 2025 · Journal of medicinal food · PMID 40955524Open on PubMed ↗
- Single Center, Open-Label, Randomized Crossover Trial on Drug-Drug Interactions of Levothyroxine/Magnesium-Citrate and Levothyroxine/Magnesium-Aspartate in Healthy Subjects-The ThyroMag Trial.Attinger MC, von Felten S, Rodrigues CL et al. · 2025 · Clinical and translational science · PMID 41221788Open on PubMed ↗
- Efficacy of Oral Magnesium on Bone Regeneration and Implant Stability in Immediate Dental Implants: A Randomized Controlled Trial.Rajanna H, Chaudhry K, Pandey AK et al. · 2025 · The International journal of oral & maxillofacial implants · PMID 38820086Open on PubMed ↗
- Effectiveness and safety of polyethylene-glycol-4000 versus sodium picosulphate plus magnesium oxide and citric acid for bowel cleansing before colonoscopy in children: A systematic review with meta-analysis.Furio S, Lucarini A, Mennini M et al. · 2025 · Journal of pediatric gastroenterology and nutrition · PMID 39400405Open on PubMed ↗
- Adenoma detection rate and tolerability of 2 ultra-low-volume bowel preparations in screening: a noninferiority randomized controlled trial.Serradesanferm A, Torá-Rocamora I, Pozo À et al. · 2025 · Gastrointestinal endoscopy · PMID 39069266Open on PubMed ↗
- Comparative Clinical Study on Magnesium Absorption and Side Effects After Oral Intake of Microencapsulated Magnesium (MAGSHAPE(TM) Microcapsules) Versus Other Magnesium Sources.Pajuelo D, Meissner JM, Negra T et al. · 2024 · Nutrients · PMID 39770988Open on PubMed ↗
- A randomized prospective study comparing the effect of low-volume bowel preparations for colonoscopy preparation in China.Shen J, Sheng H, He H et al. · 2024 · Scandinavian journal of gastroenterology · PMID 39054602Open on PubMed ↗
- Magnesium citrate monotherapy improves restless legs syndrome symptoms and multiple suggested immobilization test scores in an open-label pilot study.Gorantla S, Ravisankar A, Trotti LM · 2024 · Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · PMID 38738598Open on PubMed ↗
04 / EXPERT CONTEXT
Expert context—not evidence
Expert positions are dated context—not scientific evidence. They never raise the evidence status or become consensus by repetition.
No direct, source-verified endorsement is currently recorded. Research authorship or discussion alone is not treated as endorsement.